Eli Lilly and other drugmakers such as Pfizer are pushing to have the 466-day average wait time for medicines to be funded on the PBS to 60, which is 300 days slower than Japan, Germany and ...

SARAH FERGUSON, PRESENTER: David Ricks, welcome to 7.30. DAVID RICKS, CEO, ELI LILLY: It's great to be with you. SARAH FERGUSON: Yesterday, the Australian Federal Treasurer Jim Chalmers in ...

The prime minister and opposition leader have launched a forceful defence of Australia’s Pharmaceutical Benefits Scheme, declaring it is not for sale. America’s powerful drug lobby has thrown ...

“The Pharmaceutical Benefits Scheme is a part of who we are as Australians, and we will always stand up for it. It’s not up for negotiation.” ...

Prime Minister Anthony Albanese has declared the government will “stand our ground” against the threat of US tariffs on pharmaceutical exports because of Australia’s PBS scheme. This comes ...

The PM says the PBS is not up for negotiation, while the opposition leader says it’s the envy of the world. But how did we get this system, and how does it compare?

Australians pay some of the lowest medicine prices in the world for a reason: our Pharmaceutical Benefits Scheme. Here’s how it works and why it’s being threatened.

The powerful US pharmaceutical lobby has written to the White House, taking aim at Australia's Pharmaceutical Benefits Scheme (PBS), as President Donald Trump mulls over new tariffs.